Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3358
Gene Symbol: HTR2C
HTR2C 		0.300 Biomarker phenotype CTD_human Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. 19997080 2010
Entrez Id: 2688
Gene Symbol: GH1
GH1 		0.300 Biomarker phenotype CTD_human With the exception of pharmacologically mediated weight gain, rrGH and rmGH had no adverse effects in 5-week oral toxicity studies and no production of anti-recombinant GH antibodies. 17372281 2007
Entrez Id: 57620
Gene Symbol: STIM2
STIM2 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 3952
Gene Symbol: LEP
LEP 		0.300 Biomarker phenotype CTD_human A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. 19716478 2009
Entrez Id: 5467
Gene Symbol: PPARD
PPARD 		0.300 Therapeutic phenotype CTD_human Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways. 20176998 2010
Entrez Id: 23022
Gene Symbol: PALLD
PALLD 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 91404
Gene Symbol: SESTD1
SESTD1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 23683
Gene Symbol: PRKD3
PRKD3 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 6158
Gene Symbol: RPL28
RPL28 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 2199
Gene Symbol: FBLN2
FBLN2 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 1813
Gene Symbol: DRD2
DRD2 		0.300 Biomarker phenotype CTD_human In single-marker-based analysis, the DRD2 rs4436578-C homozygous genotype was found to be associated with a significantly increased risk of BWG [P=0.001, adjusted odds ratio=3.36 (95% confidence interval=1.62 - 7.00)]. 20375926 2010
Entrez Id: 284119
Gene Symbol: CAVIN1
CAVIN1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 3952
Gene Symbol: LEP
LEP 		0.300 Biomarker phenotype CTD_human Synthesis and evaluation of diarylthiazole derivatives that inhibit activation of sterol regulatory element-binding proteins. 21561152 2011
Entrez Id: 22919
Gene Symbol: MAPRE1
MAPRE1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 1509
Gene Symbol: CTSD
CTSD 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 51194
Gene Symbol: IPO11
IPO11 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 4232
Gene Symbol: MEST
MEST 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 4199
Gene Symbol: ME1
ME1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 7431
Gene Symbol: VIM
VIM 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 3952
Gene Symbol: LEP
LEP 		0.300 Biomarker phenotype CTD_human Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. 15070752 2004
Entrez Id: 9215
Gene Symbol: LARGE1
LARGE1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 2784
Gene Symbol: GNB3
GNB3 		0.300 Biomarker phenotype CTD_human C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. 16141801 2005
Entrez Id: 801
Gene Symbol: CALM1
CALM1 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008
Entrez Id: 5443
Gene Symbol: POMC
POMC 		0.300 Biomarker phenotype CTD_human Renal and pancreatic calcification during treatment of infantile spasms with ACTH. 6143199 1984
Entrez Id: 84064
Gene Symbol: HDHD2
HDHD2 		0.300 Biomarker phenotype CTD_human Different transcriptional control of metabolism and extracellular matrix in visceral and subcutaneous fat of obese and rimonabant treated mice. 19030233 2008